Home

szabályoz torlódás csukló cappellini and thalassemia treatments haematologica 2017 Hajnal térkép 鍔

Cureus | Efficacy and Safety of Luspatercept in the Treatment of β- Thalassemia: A Systematic Review | Article
Cureus | Efficacy and Safety of Luspatercept in the Treatment of β- Thalassemia: A Systematic Review | Article

Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering  the Expression of α-Globin Gene
Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene

JCM | Free Full-Text | Does Hepcidin Tuning Have a Role among Emerging  Treatments for Thalassemia?
JCM | Free Full-Text | Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?

Gene therapies for transfusion dependent β‐thalassemia: Current status and  critical criteria for success - Soni - 2020 - American Journal of  Hematology - Wiley Online Library
Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library

Β-Thalassemias | NEJM
Β-Thalassemias | NEJM

Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of  Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary  Myelofibrosis
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis

Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the  Horizon | Article
Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon | Article

Medicina | Free Full-Text | Non-Transfusion-Dependent Thalassemia: A  Panoramic Review
Medicina | Free Full-Text | Non-Transfusion-Dependent Thalassemia: A Panoramic Review

Quality of life in patients with β‐thalassemia: A prospective study of  transfusion‐dependent and non‐transfusion‐dependent patients in Greece,  Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of  Hematology - Wiley
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley

Coordinated β-globin expression and α2-globin reduction in a multiplex  lentiviral gene therapy vector for β-thalassemia: Molecular Therapy
Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy

A systematic review of quality of life in sickle cell disease and  thalassemia after stem cell transplant or gene therapy - ScienceDirect
A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect

Β-Thalassemias | NEJM
Β-Thalassemias | NEJM

Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Current status of beta‐thalassemia and its treatment strategies - Ali -  2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library

Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th  Edition - Version 2.0) by Thalassaemia International Federation (TIF) -  Issuu
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia  Major in Eastern Saudi Arabia | Article
Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Survival and complications in patients with haemoglobin E thalassaemia in  Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global  Health
Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global Health

Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers  as Therapeutic Targets in β–Thalassemia
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Frontiers | New Insights Into Pathophysiology of β-Thalassemia

Current status of beta‐thalassemia and its treatment strategies - Ali -  2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library

Plasma proteome profiling combined with clinical and genetic features  reveals the pathophysiological characteristics of β-thalassemia -  ScienceDirect
Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia - ScienceDirect